Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-02 05:46:01 - browse：5

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： How one medical school became remarkably diverse
Next article： SCOTUS to consider access to abortion pill mifepristone

leisure time

WSS

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Why health care costs have stayed mostly flat since 2010

After sickle

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Grail spinoff by Illumina should end disastrous merger attempt

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

explore

Wikipedia

Sign up for D.C. Diagnosis

explore

Medical records are filled with copy

Roche to buy Carmot Therapeutics, developer of obesity drugs

The high cost of giving birth even with insurance

SEC charges former device maker CEO with $41 million fraud

Guidelines to prevent youth baseball injuries need more muscle

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Dobbs anniversary: the lost opportunity of abortion as health care

SEC charges former device maker CEO with $41 million fraud

Heart attack and stroke risk calculators need revising

Readout Newsletter: The latest on Moderna, Apellis, and Merck

leisure time

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Bristol Myers buys into radiopharmaceuticals with RayzeBio

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

David Ricks of Eli Lilly: best biopharma CEO of 2023

Readout Newsletter: The latest on Moderna, Apellis, and Merck

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

focus

leisure time

knowledge

hotspot